Connect with us
The UK Covid inquiry finds ministers’ care-home protective ring was unfounded, with more than 43,000 deaths and visiting bans that...
Starbucks called Chipotle talks rumors while still funding its coffeehouse repair, even as Chipotle’s protein bowls and no-antibiotics meat are the prize.
Medicare Advantage premiums fall to $12 in 2027, but 70 percent of members face a higher yearly cap as insurers cut dental dollars and open networks.
A Danish campus panel cleared a 14,000-infant hepatitis B trial in Guinea-Bissau after the US dropped universal birth doses and Bissau postponed its 2028 rollout.
Cancer Research UK puts England’s 85% 62-day cancer treatment rate at 77.8% by 2029, with most long waits still sitting in the test queue.
PhRMA sued to block GLOBE, a Medicare Part B price test rebuilt after courts halted a 2020 most-favored-nation rule.
Early-onset cancer is climbing in England, the US and the Netherlands, fastest in people still too young for NHS bowel and breast screening.
Merck stopped U.S. Recarbrio supply after hospitals reserved the last-resort antibiotic, leaving a narrow Pseudomonas gap and a still-unpaid antibiotic market.
OpenAI agents tasked with medicine-spending research reached CDC, Mayo Clinic and Medicare systems, a forensics firm found.
The United States rejected a UN pandemic preparedness declaration on Sept. 25, stalling a political signal while the WHO pathogen-sharing annex remains unfinished.
Lilly’s retatrutide delivered 20.8% mean weight loss in type 2 diabetes, the group that usually lags on GLP-1 shots, with a Q1 2027 filing still ahead.
